Effect of Mobile Phone Telemedicine on Diabetes Care
1 other identifier
interventional
5
1 country
1
Brief Summary
Adult patients with diabetes on insulin are eligible for the study. They will be randomized to a group using standard of care communication and a group using an I phone intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes-mellitus
Started Jan 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 28, 2012
CompletedFirst Submitted
Initial submission to the registry
September 28, 2012
CompletedFirst Posted
Study publicly available on registry
October 2, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 25, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 25, 2013
CompletedResults Posted
Study results publicly available
November 2, 2018
CompletedOctober 17, 2023
October 1, 2023
1.7 years
September 28, 2012
January 29, 2018
October 4, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Evidence for Improved Diabetic Care With Mobile Phone Application Use
Satisfaction and usability was evaluated with a survey for those subjects who used the mobile phone application at the 3 and 6 months period.
Six months
Study Arms (2)
Mobile application Diabetes Doctor
EXPERIMENTALThe intervention group will send in blood glucoses once a month using the mobile phone app, Diabetes Doctor. All subjects will be evaluated at initial, 3 month, and 6 month visits. They will receive HbA1c on each visit. After 3 months, a Diabetes Quality of Life (QOL) survey will be completed. A Usability and Satisfaction of Diabetes Doctor (USDD) survey will also be obtained. At the 3 month visit, they will also be given the chance to discontinue the mobile app and switch to standard of care. At 6 months, all mobile app users will complete the USDD and satisfaction and QOL survey. If they are not using the mobile app, then they will complete the QOL survey.
Standard of Care
NO INTERVENTIONThe standard of care arm will not use the mobile application Diabetes Doctor to communicate with their physician about their blood sugars. They will attend clinic visits and have evaluations initially, and at 3 and 6 months. They will also receive a HbAIc at each visit. They will do the same QOL survey at 3 months. At 6 months, they will be given the QOL survey.
Interventions
Diabetes Doctor is a mobile application software. The mobile phone application allows a subject to register blood glucose values obtained from their fingerstick glucose meter readings, the type and amount of insulin they are administering, any notes they would like to document, and the date and time of each entry. All data will be entered by the subject manually. The data will be submitted through encryption coded private servers and can be retrievable by a physician on a password protected website for privacy. A physician will evaluate this information to recommend a change of the subject's insulin regimen. The recommended insulin regimen will be delivered to the patient using the same website and received by the subject on the same mobile application software.
Eligibility Criteria
You may qualify if:
- Type 1 or type 2 Diabetes Mellitus on insulin basal/bolus injection
- Own and are able to operate an iPhone
You may not qualify if:
- Type 2 diabetics using only oral medications
- Do not own or know how to operate an iPhone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Overall, there were difficulties with this study. We only had a small number of patients interested in participating and those that were given standard of care treatment did not continue on with the study.
Results Point of Contact
- Title
- Whitney Goldner
- Organization
- University of Nebraska Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Whitney S Goldner, MD
University of Nebraska
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 28, 2012
First Posted
October 2, 2012
Study Start
January 28, 2012
Primary Completion
September 25, 2013
Study Completion
September 25, 2013
Last Updated
October 17, 2023
Results First Posted
November 2, 2018
Record last verified: 2023-10